Cardiac drug sales: Who’s on top & who’s slipping

 - pharmaceutical, money
Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

AstraZeneca led the pack of pharmaceutical companies for revenue from cardiovascular drugs in 2014, according to a PMLive analysis. But of the top 10 companies, only Bayer and Takeda posted growth in sales that year. Here are figures for the leading companies.